The ROE as of December 2024 (TTM) for Tryp Therapeutics Inc. (TRYPF) is 131.45%

According to Tryp Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is 131.45%. This represents a change of 344.93% compared to the average of 29.54% of the last 4 quarters.

Tryp Therapeutics Inc. (TRYPF) Historical ROE (quarterly & annually)

How has TRYPF ROE performed in the past?

The mean historical ROE of Tryp Therapeutics Inc. over the last ten years is -196.17%. The current 131.45% ROE has changed -167.01% with respect to the historical average. Over the past ten years (40 quarters), TRYPF's ROE was at its highest in in the November 2022 quarter at 540.98%. The ROE was at its lowest in in the August 2022 quarter at -195.45%.

Tryp Therapeutics Inc. (TRYPF) ROE by Quarter and Year

Discovering the peaks and valleys of Tryp Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tryp Therapeutics Inc. (TRYPF) Average ROE

How has TRYPF ROE performed in the past?

The current ROE of Tryp Therapeutics Inc. (TRYPF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Tryp Therapeutics Inc. (TRYPF) ROE vs. Peers

How is TRYPF’s ROE compared to its peers?

Tryp Therapeutics Inc.’s ROE is less than PsyBio Therapeutics Corp. (0%), greater than PharmaTher Holdings Ltd. (-867.30%), greater than Awakn Life Sciences Corp. (-86.66%), less than SanBio Company Limited (231.42%), greater than Alterity Therapeutics Limited (-100.25%), greater than Amplia Therapeutics Limited (-137.73%), greater than Adynxx, Inc. (-34.42%), greater than Nxera Pharma Co., Ltd. (0%), greater than Biostage, Inc. (-5.51%), greater than Antibe Therapeutics Inc. (-129.88%), greater than America Great Health (-49.77%), less than Cellectis S.A. (18.81%), greater than Biotron Limited (-75.49%), greater than Regenicin, Inc. (-423.05%), greater than AXIM Biotechnologies, Inc. (0%), less than Bioasis Technologies Inc. (54.15%), greater than Nova Mentis Life Science Corp. (0%), less than HAVN Life Sciences Inc. (73.69%), greater than null (0%),

Build a custom stock screener for Tryp Therapeutics Inc. (TRYPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tryp Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tryp Therapeutics Inc. (TRYPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tryp Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.